Global Fluoroscopy and C-Arm Market, by Product Type (C-Arms, (Full Size C – arms, Mini C – arms), Fluoroscopy Devices), by End User (Hospitals, Specialty Clinics, Diagnostic Centres), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$  3,872.1 Million in 2022 and is expected to exhibit a CAGR of 4.6% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

Major players in the global fluoroscopy and c-arms market are focused on signing agreements and partnership strategies to enhance their market share, is expected to drive the growth of global fluoroscopy and c-arms market over the forecast period. For instance, in July 2020, Turner Imaging Systems, an X-ray equipment supplier, entered into a master reseller’s agreement with Siemens Healthineers, a healthcare company, which will add the Smart-C Mini C-Arm to the Siemens Healthineers portfolio of radiology and imaging products. As a result of this agreement, Siemens Healthineers become the premium partner reseller to the hospital sector.           

Moreover, increasing prevalence of orthopedic diseases is expected to propel growth of the global fluoroscopy and c-arms market over the forecast period. For instance, according to the study, “Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017”, published in the journal Annals of the Rheumatic Diseases, in November 2019, the age-standardized point prevalence and annual incidence rates of rheumatoid arthritis were 246.6 and 14.9 in 2017, which increased by 7.4% and 8.2% from 1990, respectively.

Global Fluoroscopy and C-Arm Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

However, the COVID-19 pandemic had a negative impact on market, owing to the decrease in surgical procedures in the U.S. during the COVID-19 pandemic. For instance according to an article published on December 8, 2021 by Journal of the American Medical Association, the overall rate of surgical procedures such as Orthopaedic surgeries, Laminectomy, etc. decreased by 48.0% during the initial COVID-19 shutdown in the U.S. i.e., from January 1, 2019, to January 30, 2021. The decrease in surgical procedures had reduced the use of endoscopy devices during COVID-19 pandemic.

Global Fluoroscopy and C-Arm Market: Key Developments

For instance, in August 2020, Ziehm Imaging, a developer and manufacturer of mobile X-ray-based imaging solutions, acquired Therenva, a France-based developer of planning and imaging software tools for cardiovascular procedures. Through this acquisition, Ziehm will use its mobile C-Arm angiography system distribution network to promote Therenva's product line internationally.

Browse 22 Market Data Tables and 14 Figures spread through 170 Pages and in-depth TOC on “Global Fluoroscopy and C-Arm Market”- Forecast to 2030, Global Fluoroscopy and C-Arm Market, by Product Type (C-Arms, (Full Size C – arms, Mini C – arms), Fluoroscopy Devices), by End User (Hospitals, Specialty Clinics, Diagnostic Centres), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)  

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/fluoroscopy-and-c-arm-market-510

Major market players are involved in inorganic growth strategies such as partnership which is expected to drive the growth of global fluoroscopy and c-arm market over the forecast period. For instance, on January 18, 2022 Koninklijke Philips N.V., a health technology company, had signed a strategic partnership agreement with Cydar, a provider of cloud-based procedure maps software to plan and guide surgery, and announced that physicians will have access to advanced new 3D image guidance capabilities through its Image-Guided Therapy Mobile C-Arm System, Zenition, providing better clinical accuracy and efficiency, and aiming to improve the outcomes for patients undergoing endovascular treatment.

Key Takeaways of the Global Fluoroscopy and C-Arm Market:

  • Global fluoroscopy and c-arm market is expected to exhibit a CAGR of 4.6% during the forecast period due to involvement of key market players in inorganic activities such as acquisition for strengthen their product portfolio. For instance, on March 1, 2022, Canon Medical Systems Corporation, a medical equipment company, announced an agreement to acquire Nordisk Rontgen Teknik A/S, a manufacturer of diagnostic X-ray systems. Through this acquisition, Canon Medical will have access to manufacturing and technology that are situated in Europe and will have the chance to use advance technology for multipurpose fluoroscopy.
  • Among product type segment, fluoroscopy devices segment is expected to exhibit highest CAGR in the global fluoroscopy and C-Arm market during the forecast period this is attributed to increasing product launches. For instance, on September 30, 2021, Siemens Healthcare GmbH, a healthcare company, launched Luminos Impulse, a fluoroscopy system with a new features such as a seamless imaging chain, comprehensive dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.
  • Among regions, North America is estimated to account for the largest market share in the global fluoroscopy and c-arm market, due to increasing product launch by key market players in U.S. market. For instance, in November, 2020, FUJIFILM Holdings America Corporation, a diagnostic and medical informatics solutions company, has entered the U.S. surgical C-Arm and radiographic fluoroscopy markets with two systems i.e., the Persona C Surgical C- Arm and Persona RF premium system.
  • Major players operating in the global fluoroscopy and C-Arm market include GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Hologic, Inc., and Ziehm Imaging.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo